Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001362310-09-005240
Filing Date
2009-04-13
Accepted
2009-04-13 14:12:14
Documents
1
Period of Report
2009-05-12
Effectiveness Date
2009-04-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A c83831def14a.htm DEF 14A 340442
  Complete submission text file 0001362310-09-005240.txt   341985
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-80623 | Film No.: 09746364
SIC: 2835 In Vitro & In Vivo Diagnostic Substances